These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1134 related items for PubMed ID: 16856909

  • 1. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
    Grassinger J, Mueller G, Zaiss M, Kunz-Schughart LA, Andreesen R, Hennemann B.
    Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
    [Abstract] [Full Text] [Related]

  • 2. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
    Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H, Mitsui T, Manabe A, Tanaka R, Kobayashi K, Ito M, Yasukawa K, Nakahata T.
    J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
    [Abstract] [Full Text] [Related]

  • 3. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J, Oez S, Smetak M, Kaiser G, Kappauf H, Gallmeier WM.
    Stem Cells; 1997 Apr; 15(1):18-32. PubMed ID: 9007219
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distinct actions of Flt3 ligand and stem cell factor on myeloid lineage selection and maturation of granulocytes versus macrophages.
    Dannaeus K, Nilsson K, Jönsson JI.
    Exp Hematol; 1998 Apr; 26(4):345-52. PubMed ID: 9546318
    [Abstract] [Full Text] [Related]

  • 6. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M, Nissen C, Manz CY, Toksoz D, Lyman SD, Wodnar-Filipowicz A.
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [Abstract] [Full Text] [Related]

  • 7. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation.
    Drouet M, Mathieu J, Grenier N, Multon E, Sotto JJ, Herodin F.
    Stem Cells; 1999 May; 17(5):273-85. PubMed ID: 10527462
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
    Veiby OP, Jacobsen FW, Cui L, Lyman SD, Jacobsen SE.
    J Immunol; 1996 Oct 01; 157(7):2953-60. PubMed ID: 8816402
    [Abstract] [Full Text] [Related]

  • 10. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G, Milazzo L, Vulcano F, Pascuccio M, Macioce G, Hassan HJ, Giampaolo A.
    Exp Hematol; 2008 Feb 01; 36(2):244-52. PubMed ID: 18023520
    [Abstract] [Full Text] [Related]

  • 11. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
    Nishino T, Miyaji K, Ishiwata N, Arai K, Yui M, Asai Y, Nakauchi H, Iwama A.
    Exp Hematol; 2009 Nov 01; 37(11):1364-1377.e4. PubMed ID: 19744539
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS, Miranda N, Muller EJ, Hekman A, Kerst JM, de Gast GC, Gerritsen WR.
    Exp Hematol; 1998 Aug 01; 26(9):885-94. PubMed ID: 9694510
    [Abstract] [Full Text] [Related]

  • 14. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T, Schröder B, Bug G, Müller P, Klenner T, Knaus R, Hoelzer D, Ottmann OG.
    Stem Cells; 2001 Aug 01; 19(4):313-20. PubMed ID: 11463951
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
    Lazzari L, Henschler R, Lecchi L, Rebulla P, Mertelsmann R, Sirchia G.
    Haematologica; 2000 Jan 01; 85(1):25-30. PubMed ID: 10629587
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synergistic effects of stem cell factor and interleukin 6 or interleukin 11 on the expansion of murine hematopoietic progenitors in liquid suspension culture.
    Ariyama Y, Misawa S, Sonoda Y.
    Stem Cells; 1995 Jul 01; 13(4):404-13. PubMed ID: 7549899
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.